Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes
1995
Tenascin and Oncofetal Fibronectin in Cancer
publication
Author Information
Author(s): L David, M Sobrinho-Simoes
Primary Institution: IPATIMUP, Medical Faculty of Porto, Hospital S. Joao
Hypothesis
Is tenascin an indicator of extracellular matrix remodeling in gastric cancer?
Conclusion
The study suggests that tenascin and oncofetal fibronectin are not strictly associated with malignancy and may be influenced by other conditions.
Supporting Evidence
- Tenascin is expressed in the fibrous stroma surrounding cancer in 41% of primary tumors and 32% of lymph node metastases.
- Tenascin expression did not correlate with cancer parameters like differentiation or prognosis.
- Oncofetal fibronectin was found in both cancerous and non-cancerous conditions.
Takeaway
The study looks at two proteins related to cancer, but they can also show up in non-cancer situations, which can be confusing.
Potential Biases
Potential for false-positive results due to other conditions mimicking cancer.
Limitations
The study did not analyze precursor lesions or non-cancerous conditions that could affect tenascin expression.
Want to read the original?
Access the complete publication on the publisher's website